Dr. Philip L. Mar, M.D., PHARM.D.
Cardiac Electrophysiology (Clinical Cardiac Electrophysiology Physician)
- Medicare participating
At a glance
- Medical school
- Medical College of Georgia School of Medicine (2011)
- Years since graduation
- 15
- In the NPI registry since
- 2011
- Medicare patients seen, 2024
- 961
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2011Medical school: Medical College of Georgia School of Medicine
- 2011Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Clinical Cardiac Electrophysiology Physician primary
MO license 2019015018 -
Cardiovascular Disease Physician
MO license 2019015018
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Ssm Health Saint Louis University Hospital Saint Louis, MO
- Ssm Health St Mary's Hospital - St Louis Saint Louis, MO
- Heartland Regional Medical Center Marion, IL
Medical groups
- Ssm Health Care Group (940 clinicians)
- Deaconess Illinois Specialty Clinic, Inc. (148 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 961
- Services billed
- 2,125
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 413 | 293 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 297 | 82 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 293 | 81 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 97 | 82 |
| Established patient office or other outpatient visit, 20-29 minutes | 96 | 72 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 84 | 52 |
| Established patient office or other outpatient visit, 30-39 minutes | 76 | 61 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 48 | 31 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 47 | 29 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 41 | 21 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Metoprolol Succinate Other prescribers in Saint Louis, MO | 203 |
| Eliquis (apixaban) Other prescribers in Saint Louis, MO | 177 |
| Dofetilide | 88 |
| Atorvastatin Calcium Other prescribers in Saint Louis, MO | 81 |
| Xarelto (rivaroxaban) Other prescribers in Saint Louis, MO | 79 |
| Furosemide Other prescribers in Saint Louis, MO | 77 |
| Carvedilol Other prescribers in Saint Louis, MO | 68 |
| Amiodarone Hcl Other prescribers in Saint Louis, MO | 64 |
| Flecainide Acetate Other prescribers in Saint Louis, MO | 54 |
| Metoprolol Tartrate Other prescribers in Saint Louis, MO | 46 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 7 companies reported 45 payments worth $4,766 in total to this clinician.
| Abbott Laboratories | $2,258 |
|---|---|
| Medtronic, Inc. | $1,958 |
| Biosense Webster, Inc. | $283 |
| Atricure, Inc. | $192 |
| Pfizer Inc. | $34.88 |
| Abiomed | $20.73 |
| Novartis Pharmaceuticals Corporation | $18.79 |
| Travel and Lodging | $2,832 |
|---|---|
| Food and Beverage | $1,934 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Medtronic, Inc. Sep 18, 2025 | Travel and Lodging travel to Wilkes-Barre, PA · in-kind | $1,566 |
| Abbott Laboratories Aug 18, 2025 | Travel and Lodging AVEIR · Structural Heart · travel to Phoenix, AZ · in-kind | $615 |
| Abbott Laboratories Aug 18, 2025 | Travel and Lodging AVEIR · Structural Heart · travel to Phoenix, AZ · in-kind | $256 |
| Abbott Laboratories Oct 7, 2025 | Travel and Lodging AVEIR · Structural Heart · travel to Phoenix, AZ · in-kind | $166 |
| Abbott Laboratories Oct 7, 2025 | Travel and Lodging AVEIR · Structural Heart · travel to Phoenix, AZ · in-kind | $166 |
| Abbott Laboratories Oct 7, 2025 | Travel and Lodging AVEIR · Structural Heart · travel to Phoenix, AZ · in-kind | $54.15 |
| Abbott Laboratories Aug 18, 2025 | Travel and Lodging AVEIR · Structural Heart · travel to Phoenix, AZ · in-kind | $9.02 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $7,963 in research payments for these studies, mostly to the institutions running them.
- LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System.
Boston Scientific Corporation · Completed · NCT04790344
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.